Parabolica Therapeutics, Inc.

DALLAS, TX · Founded 2025 · CIK 0002128979 · Biotech · Private

Proprietary peptide conjugation technologies for obesity and metabolic disease therapeutics

parabolicatx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$50K
1 Form D · Apr 2026
5 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$50,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3058TFC BIOSCIENCES, INC.——
3059NEOCHROMOSOME, INC.——
3060RNA NANOTHERAPEUTICS LLC——
3061Parabolica Therapeutics, Inc.—$50K
3062Centessa Pharmaceuticals——
3063Entrega——
3064Nested Therapeutics——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Brian BrilleDirector
  • Narendra ChokshiDirector · Executive Officer
  • Andrew WangDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.